Pharmaceutical manufacturer for Vitamin d3

Established in Darmstadt, Germany in 1668 by Friedrich Jacob Merck, Merck KGaA stands as the oldest pharmaceutical and chemical corporation globally. It is renowned for its pioneering and high-quality advanced products in the fields of healthcare, life science, and performance materials. Internationally, the company is recognized as Merck, while operating as EMD Serono in the Biopharma sector, as MilliporeSigma in the Life Science sector, and as EMD Performance Materials in the materials sector in the United States and Canada.

Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad, deep-scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred Contract Development and Manufacturing Organization (CDMO) partner for personalized medicines, blockbuster drugs and consumer health brand extensions. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply over 80 billion doses of nearly 8,000 products annually. Its rapidly growing expert workforce exceeds 18,000, including more than 3,000 scientists and technicians. Headquartered in Somerset, New Jersey, Catalent, Inc. (NYSE:CTLT), is in S&P 500® company, and generated nearly $5 billion in revenue in its 2022 fiscal year.

Transo-Pharm, a fully authorized and accredited distributor, specializes in pharmaceutical components for the medical and veterinary sectors. It provides assistance to customers throughout the entire API life cycle, from product innovation to sales. Transo-Pharm acts as a sourcing and regulatory marketing representative for API producers. It assists customers in establishing DMFs and offers GMP advisory services. With a dedicated regulatory division, a storage facility, proprietary IPs for API procedures, and collaborations with research facilities, Transo-Pharm offers a broad array of services. It operates from its establishments in Shanghai, Hong Kong, Singapore, and the United States.

Formosa Laboratories serves customers globally as a leading supplier of active pharmaceutical ingredients (APIs). They offer a comprehensive range of CDMO services, including the development and production of APIs, ADCs, and cytotoxic and non-cytotoxic injectables using aseptic liquid filling and lyophilization processes. Formosa Laboratories is equipped to provide full-service GMP manufacturing for drug substances, ADCs, and drug products through its API and injectable facilities, which are designed to accommodate small molecules and more.

Zim offers innovative solutions for administering medications, focusing on enhancing patient convenience and compliance. The company utilizes its own advanced technologies, such as modified release and taste masking, to create and produce distinct pharmaceutical products. Their range includes oral solid dosage formulations and pre-formulations (PFI), encompassing tablets, capsules, dry syrups, pellets, granules, and orally disintegrating strips (ODS). Additionally, they provide services for site transfer/variation for sustained release tablets, oral disintegrating tablets, fast disintegrating capsules, and more.

Established in 2004, Murli Krishna Pharma Pvt Ltd is a youthful and dynamic organization specializing in Novel Drug Delivery Systems (NDDS). It offers a variety of effective solutions for enhancing the delivery of pharmaceutical products. The current operations involve the production of pre-finished formulations such as Pellets, Granules, and MUPS using Aqueous Based technology, Nano Particles, and Transdermal Oil. The facility is furnished with state-of-the-art machinery and 21 CFR, part 11 compliant instruments.

HASCO-LEK is a pharmaceutical company in Poland specialized in producing generic pharmaceuticals and medical devices, offering CTD Dossiers (OTC, Rx) and licensed or distributed products. They also provide contract manufacturing with technology transfer or development options for pharmaceutical products and food supplements, including soft-gel capsules, liquids, semi-liquids, tablets, gels, suppositories, and sachets. Their business models include in & out licensing, export, distribution, and contract manufacturing.

Our corporation is the leading manufacturer of Vitamin D2 in the People's Republic of China. We have obtained the GMP certification and successfully completed KOSHER verification in 2004. The organization is the proprietor of the renowned Golden Moutain brand and has been officially registered in the United States, United Kingdom, Germany, Denmark, Russia, Australia, Japan, and South Korea.

Alter Pharma is a pharmaceutical group based in Anderlecht, Belgium, with offices in Ireland and the United States. With a workforce of more than 125 employees, the company distributes a diverse range of pharmaceutical products to pharmacies, wholesalers, hospitals, and retirement homes. Additionally, Alter Pharma is a major player in the global generics market, with approximately 15 months of presence.

IBSA is a privately-held pharmaceutical company, established in Lugano in 1945. Due to a well-established expansion plan, IBSA distributes its products across 5 continents and more than 90 nations, including countries in Europe, China, and the United States. The group currently has 2,000 employees working in various offices and production facilities spanning 17 subsidiaries located in Europe, China, and the United States, while 14 Research and Development laboratories employ 125 individuals. Presently, the IBSA Group holds 90 patent families, with additional patents in the pipeline.

Sichuan Province Yuxin Pharmaceutical Co.,Ltd has been committed to manufacturing the API for numerous years and has been awarded the GMP certificate. The API products comprise Vitamins (Vitamin D2, Vitamin D3), Plant extract (Rutin, Berberine Hydrochloride, Rotundine, Puerarin, Baicalin, Andrographolide), and Chemical Synthesis (Lidocaine hydrochloride, Diphenhydramine Hydrochloride, Frusemide). Established in 1995, we obtained the GMP certificate and gained Indian Registration from DCGI in 2010. In a bid to facilitate future development and meet the demands of the international market, the company has adopted the most advanced intelligent production and testing equipment in China, and is focused on product optimization and R&D.